Larimar Therapeutics, Inc.
LRMRNasdaqCIK 1374690HealthcareFiscal year ends Dec 31
Reports and events: 238 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-2920:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-407331 |
| 2026-08-0411:12 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-331529 |
| 2026-08-0411:02 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-331516 |
| 2026-06-2910:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-286780 |
| 2026-05-1920:27 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-230852 |
| 2026-05-1420:18 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-224087 |
| 2026-05-1411:02 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-222746 |
| 2026-04-2020:06 ET | DEF 14A | Proxy statementPeriod 2026-04-17 | 0001193125-26-163942 |
| 2026-03-1919:41 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-115878 |
| 2026-03-1911:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-115119 |
| 2026-03-0920:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-098493 |
| 2026-03-0200:46 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193805-26-000206 |
| 2026-02-2722:48 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-077646 |
| 2026-02-2412:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-065186 |
| 2026-01-2212:00 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-26-018664 |
| 2026-01-1221:18 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-010409 |
| 2025-12-1713:00 ET | 8-K | 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-25-321738 |
| 2025-11-1012:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-273217 |
| 2025-11-0521:15 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-266969 |
| 2025-11-0512:03 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-265702 |
| 2025-10-1411:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-237998 |
| 2025-09-2911:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-221538 |
| 2025-08-1419:36 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-108797 |
| 2025-08-1411:02 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-108409 |
| 2025-07-3122:26 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193805-25-001138 |
| 2025-07-3110:05 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-169818 |
| 2025-07-2921:01 ET | 8-K | 2.02 Results of operations | 0001193125-25-168096 |
| 2025-06-2321:13 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-089074 |
| 2025-06-2311:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-088704 |
| 2025-05-1320:03 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-070287 |
| 2025-05-0510:33 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-063125 |
| 2025-04-3021:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-061222 |
| 2025-04-3011:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-060563 |
| 2025-04-1111:42 ET | DEF 14A | Proxy statementPeriod 2025-04-09 | 0000950170-25-053028 |
| 2025-03-2420:51 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-043925 |
| 2025-03-2411:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-043487 |
| 2025-01-2721:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-009196 |
| 2025-01-1012:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-003794 |
| 2024-12-1612:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-136384 |
| 2024-11-1812:02 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-127768 |
| 2024-10-3021:03 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-119100 |
| 2024-10-3011:03 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-118586 |
| 2024-08-0818:38 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-093733 |
| 2024-08-0711:02 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-092265 |
| 2024-06-1010:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-071056 |
| 2024-05-3120:07 ET | 8-K | 5.07 Shareholder vote results | 0000950170-24-067306 |
| 2024-05-3020:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-066571 |
| 2024-05-2020:08 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-062387 |
| 2024-05-0920:11 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-056965 |
| 2024-05-0911:02 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-056248 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.